PortfoliosLab logoPortfoliosLab logo
VRNA vs. TEC.TO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

VRNA vs. TEC.TO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and TD Global Technology Leaders Index ETF (TEC.TO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

VRNA is traded in USD, while TEC.TO is traded in CAD. To make them comparable, the TEC.TO values have been converted to USD using the latest available exchange rates.

Returns By Period


VRNA

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

TEC.TO

1D
0.20%
1M
-2.32%
YTD
10.53%
6M
11.61%
1Y
31.73%
3Y*
26.66%
5Y*
15.37%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

VRNA vs. TEC.TO - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
VRNA
Verona Pharma plc
0.00%130.21%133.60%-23.92%288.84%-4.00%21.74%-10.85%
TEC.TO
TD Global Technology Leaders Index ETF
10.53%20.97%34.24%57.02%-36.24%25.52%51.13%16.34%

Correlation

The correlation between VRNA and TEC.TO is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (All Time)
Calculated using the full available price history since May 9, 2019

0.14

The correlation between VRNA and TEC.TO shifts across timeframes, from 0.03 (1 year) to 0.17 (5 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VRNA vs. TEC.TO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


TEC.TO
TEC.TO Risk / Return Rank: 5454
Overall Rank
TEC.TO Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
TEC.TO Sortino Ratio Rank: 5959
Sortino Ratio Rank
TEC.TO Omega Ratio Rank: 6262
Omega Ratio Rank
TEC.TO Calmar Ratio Rank: 4343
Calmar Ratio Rank
TEC.TO Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. TEC.TO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and TD Global Technology Leaders Index ETF (TEC.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VRNATEC.TODifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.29

Calmar ratioReturn relative to maximum drawdown

1.77

Martin ratioReturn relative to average drawdown

5.75

VRNA vs. TEC.TO - Sharpe Ratio Comparison


Loading charts...

Drawdowns

VRNA vs. TEC.TO - Drawdown Comparison


Loading charts...

Drawdown Indicators


VRNATEC.TODifference

Max Drawdown

Largest peak-to-trough decline

-40.52%

Max Drawdown (1Y)

Largest decline over 1 year

-17.18%

Max Drawdown (3Y)

Largest decline over 3 years

-24.68%

Max Drawdown (5Y)

Largest decline over 5 years

-40.52%

Current Drawdown

Current decline from peak

-6.11%

Average Drawdown

Average peak-to-trough decline

-9.14%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.28%

Volatility

VRNA vs. TEC.TO - Volatility Comparison


Loading charts...

Volatility by Period


VRNATEC.TODifference

Volatility (1M)

Calculated over the trailing 1-month period

7.22%

Volatility (6M)

Calculated over the trailing 6-month period

14.58%

Volatility (1Y)

Calculated over the trailing 1-year period

18.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.42%

Dividends

VRNA vs. TEC.TO - Dividend Comparison

VRNA has not paid dividends to shareholders, while TEC.TO's dividend yield for the trailing twelve months is around 0.10%.


PositionTTM2025202420232022202120202019
TEC.TO
TD Global Technology Leaders Index ETF
0.10%0.13%0.12%0.21%0.31%0.22%0.33%0.28%
VRNA
Verona Pharma plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


VRNA and TEC.TO have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for VRNA and TEC.TO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer